Bradley Merrill Thompson, a Member of the Firm at Epstein Becker Green, commented on the FDA’s regulation of mobile medical apps in a Healthcare Finance News article on June 20. “In the rush to regulate the fast-growing industry of mobile medical apps, Congress has apparently sidestepped a potential power struggle with the Food and Drug Administration over the agency’s authority to regulate them.“
Medical, Health Care & Biotechnology Policy and Advisory Services in U.S. and International
EBG Advisor, Bradley Merrill Thompson, Comments on FDA Regulation of Mobile Medical Apps in Healthcare Finance News
June 21, 2012 | Announcements | less than a minute